Feng Tian1, Jinlong Zhao2, Xinlei Fan3, Zhenxing Kang4. 1. Department of Respiratory Medicine, Linyi People's Hospital, Linyi 276000, China. 2. Department of Thoracic Surgery, Linyi People's Hospital, Linyi 276000, China. 3. Department of Internal Medicine, Shandong Medical College, Linyi 276000, China. 4. Department of Respiratory Medicine, The Third People's Hospital of Linyi, Linyi 276000, China.
Abstract
BACKGROUND: Lung squamous cell carcinoma (lung SCC) is a common type of malignancy. Its pathogenesis mechanism of tumor development is unclear. The aim of this study was to identify key genes for diagnosis biomarkers in lung SCC metastasis. METHODS: We searched and downloaded mRNA expression data and clinical data from The Cancer Genome Atlas (TCGA) database to identify differences in mRNA expression of primary tumor tissues from lung SCC with and without metastasis. Gene co-expression network analysis, protein-protein interaction (PPI) network, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and quantitative real-time polymerase chain reactions (qRT-PCR) were used to explore the biological functions of the identified dysregulated genes. RESULTS: Four hundred and eighty-two differentially expressed genes (DEGs) were identified between lung SCC with and without metastasis. Nineteen modules were identified in lung SCC through weighted gene co-expression network analysis (WGCNA). Twenty-three DEGs and 26 DEGs were significantly enriched in the respective pink and black module. KEGG pathway analysis displayed that 26 DEGs in the black module were significantly enriched in bile secretion pathway. Forty-nine DEGs in the two gene co-expression module were used to construct PPI network. CFTR in the black module was the hub protein, had the connectivity with 182 genes. The results of qRT-PCR displayed that FIGF, SFTPD, DYNLRB2 were significantly down-regulated in the tumor samples of lung SCC with metastasis and CFTR, SCGB3A2, SSTR1, SCTR, ROPN1L had the down-regulation tendency in lung SCC with metastasis compared to lung SCC without metastasis. CONCLUSIONS: The dysregulated genes including CFTR, SCTR and FIGF might be involved in the pathology of lung SCC metastasis and could be used as potential diagnosis biomarkers or therapeutic targets for lung SCC.
BACKGROUND:Lung squamous cell carcinoma (lung SCC) is a common type of malignancy. Its pathogenesis mechanism of tumor development is unclear. The aim of this study was to identify key genes for diagnosis biomarkers in lung SCC metastasis. METHODS: We searched and downloaded mRNA expression data and clinical data from The Cancer Genome Atlas (TCGA) database to identify differences in mRNA expression of primary tumor tissues from lung SCC with and without metastasis. Gene co-expression network analysis, protein-protein interaction (PPI) network, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and quantitative real-time polymerase chain reactions (qRT-PCR) were used to explore the biological functions of the identified dysregulated genes. RESULTS: Four hundred and eighty-two differentially expressed genes (DEGs) were identified between lung SCC with and without metastasis. Nineteen modules were identified in lung SCC through weighted gene co-expression network analysis (WGCNA). Twenty-three DEGs and 26 DEGs were significantly enriched in the respective pink and black module. KEGG pathway analysis displayed that 26 DEGs in the black module were significantly enriched in bile secretion pathway. Forty-nine DEGs in the two gene co-expression module were used to construct PPI network. CFTR in the black module was the hub protein, had the connectivity with 182 genes. The results of qRT-PCR displayed that FIGF, SFTPD, DYNLRB2 were significantly down-regulated in the tumor samples of lung SCC with metastasis and CFTR, SCGB3A2, SSTR1, SCTR, ROPN1L had the down-regulation tendency in lung SCC with metastasis compared to lung SCC without metastasis. CONCLUSIONS: The dysregulated genes including CFTR, SCTR and FIGF might be involved in the pathology of lung SCC metastasis and could be used as potential diagnosis biomarkers or therapeutic targets for lung SCC.
Authors: Kristjan Välk; Tõnu Vooder; Raivo Kolde; Mari-Ann Reintam; Cathleen Petzold; Jaak Vilo; Andres Metspalu Journal: Oncology Date: 2011-03-16 Impact factor: 2.935
Authors: Ji Woong Son; Young Jin Kim; Hyun Min Cho; Soo Young Lee; Su Man Lee; Jae-Ku Kang; Jung Uee Lee; Yu Mi Lee; Sun Jung Kwon; Eugene Choi; Moon Jun Na; Jae Yong Park; Dong Sun Kim Journal: Respirology Date: 2011-11 Impact factor: 6.424
Authors: T Le Chevalier; G Scagliotti; R Natale; S Danson; R Rosell; R Stahel; P Thomas; R M Rudd; J Vansteenkiste; N Thatcher; C Manegold; J-L Pujol; N van Zandwijk; C Gridelli; J P van Meerbeeck; L Crino; A Brown; P Fitzgerald; M Aristides; J H Schiller Journal: Lung Cancer Date: 2005-01 Impact factor: 5.705
Authors: Marcello Tiseo; Francesco Gelsomino; Roberta Alfieri; Andrea Cavazzoni; Cecilia Bozzetti; Anna Maria De Giorgi; Pier Giorgio Petronini; Andrea Ardizzoni Journal: Cancer Treat Rev Date: 2015-05-01 Impact factor: 12.111
Authors: Badan Sehrawat; Malinee Sridharan; Sunita Ghosh; Paula Robson; Carol E Cass; John R Mackey; Russell Greiner; Sambasivarao Damaraju Journal: Hum Genet Date: 2011-03-19 Impact factor: 4.132
Authors: Andrew Chatr-Aryamontri; Bobby-Joe Breitkreutz; Rose Oughtred; Lorrie Boucher; Sven Heinicke; Daici Chen; Chris Stark; Ashton Breitkreutz; Nadine Kolas; Lara O'Donnell; Teresa Reguly; Julie Nixon; Lindsay Ramage; Andrew Winter; Adnane Sellam; Christie Chang; Jodi Hirschman; Chandra Theesfeld; Jennifer Rust; Michael S Livstone; Kara Dolinski; Mike Tyers Journal: Nucleic Acids Res Date: 2014-11-26 Impact factor: 19.160
Authors: Christiaan G J Saris; Steve Horvath; Paul W J van Vught; Michael A van Es; Hylke M Blauw; Tova F Fuller; Peter Langfelder; Joseph DeYoung; John H J Wokke; Jan H Veldink; Leonard H van den Berg; Roel A Ophoff Journal: BMC Genomics Date: 2009-08-27 Impact factor: 3.969